A detailed history of Chicago Capital, LLC transactions in Edwards Lifesciences Corp stock. As of the latest transaction made, Chicago Capital, LLC holds 146,725 shares of EW stock, worth $13.5 Million. This represents 0.43% of its overall portfolio holdings.

Number of Shares
146,725
Previous 157,530 6.86%
Holding current value
$13.5 Million
Previous $12 Million 16.73%
% of portfolio
0.43%
Previous 0.44%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 15, 2024

SELL
$72.54 - $95.56 $783,794 - $1.03 Million
-10,805 Reduced 6.86%
146,725 $14 Million
Q4 2023

Jan 22, 2024

SELL
$61.71 - $77.76 $1.16 Million - $1.46 Million
-18,829 Reduced 10.68%
157,530 $12 Million
Q3 2023

Oct 25, 2023

SELL
$69.28 - $93.38 $212,204 - $286,022
-3,063 Reduced 1.71%
176,359 $12.2 Million
Q2 2023

Jul 20, 2023

SELL
$81.41 - $94.33 $81,165 - $94,047
-997 Reduced 0.55%
179,422 $16.9 Million
Q1 2023

Apr 18, 2023

SELL
$74.26 - $84.51 $19.6 Million - $22.3 Million
-263,351 Reduced 59.34%
180,419 $14.9 Million
Q4 2022

Jan 20, 2023

SELL
$68.3 - $87.44 $3.23 Million - $4.13 Million
-47,241 Reduced 9.62%
443,770 $0
Q3 2022

Oct 14, 2022

SELL
$82.37 - $107.29 $343,235 - $447,077
-4,167 Reduced 0.84%
491,011 $40.6 Million
Q2 2022

Jul 21, 2022

BUY
$86.5 - $128.27 $2.51 Million - $3.73 Million
29,062 Added 6.23%
495,178 $47.1 Million
Q1 2022

Apr 21, 2022

BUY
$101.96 - $128.34 $1.56 Million - $1.96 Million
15,255 Added 3.38%
466,116 $54.9 Million
Q4 2021

Jan 20, 2022

SELL
$106.37 - $130.68 $660,025 - $810,869
-6,205 Reduced 1.36%
450,861 $58.4 Million
Q3 2021

Oct 28, 2021

SELL
$102.91 - $122.75 $349,173 - $416,490
-3,393 Reduced 0.74%
457,066 $51.7 Million
Q2 2021

Jul 22, 2021

SELL
$83.84 - $104.76 $73,360 - $91,665
-875 Reduced 0.19%
460,459 $47.7 Million
Q1 2021

Apr 13, 2021

BUY
$78.68 - $90.67 $467,752 - $539,033
5,945 Added 1.31%
461,334 $38.6 Million
Q4 2020

Jan 25, 2021

BUY
$71.69 - $91.23 $7.71 Million - $9.81 Million
107,585 Added 30.93%
455,389 $41.5 Million
Q3 2020

Oct 13, 2020

BUY
$67.19 - $87.44 $2,015 - $2,623
30 Added 0.01%
347,804 $27.8 Million
Q2 2020

Jul 29, 2020

BUY
$57.54 - $76.95 $13.4 Million - $17.9 Million
233,180 Added 203.48%
347,774 $24 Million
Q1 2020

Apr 21, 2020

SELL
$52.41 - $81.0 $1.95 Million - $3.02 Million
-37,238 Reduced 24.53%
114,594 $21.6 Million
Q4 2019

Jan 14, 2020

SELL
$71.7 - $82.09 $268,373 - $307,262
-3,743 Reduced 2.41%
151,832 $35.4 Million
Q3 2019

Oct 29, 2019

SELL
$61.55 - $75.43 $3.5 Million - $4.29 Million
-56,876 Reduced 26.77%
155,575 $34.2 Million
Q2 2019

Jul 11, 2019

BUY
$55.74 - $64.41 $414,092 - $478,501
7,429 Added 3.62%
212,451 $39.2 Million
Q1 2019

Apr 23, 2019

SELL
$47.89 - $64.05 $211,865 - $283,357
-4,424 Reduced 2.11%
205,022 $39.2 Million
Q4 2018

Feb 11, 2019

SELL
$46.41 - $56.94 $67,016 - $82,221
-1,444 Reduced 0.68%
209,446 $32.1 Million
Q3 2018

Nov 02, 2018

BUY
$45.7 - $58.03 $1.1 Million - $1.4 Million
24,131 Added 12.92%
210,890 $36.7 Million
Q2 2018

Jul 19, 2018

BUY
$42.45 - $51.3 $2.52 Million - $3.05 Million
59,392 Added 46.63%
186,759 $27.2 Million
Q1 2018

May 09, 2018

BUY
$37.19 - $47.45 $4.74 Million - $6.04 Million
127,367 New
127,367 $17.8 Million

Others Institutions Holding EW

About Edwards Lifesciences Corp


  • Ticker EW
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 618,259,968
  • Market Cap $57.1B
  • Description
  • Edwards Lifesciences Corporation provides products and technologies for structural heart disease, and critical care and surgical monitoring in the United States, Europe, Japan, and internationally. It offers transcatheter heart valve replacement products for the minimally invasive replacement of heart valves; and transcatheter heart valve repair...
More about EW
Track This Portfolio

Track Chicago Capital, LLC Portfolio

Follow Chicago Capital, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Chicago Capital, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Chicago Capital, LLC with notifications on news.